Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Chatzistamou

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cell Stress & Chaperones|June 25, 2020
Coordination of the unfolded protein response during hepatic steatosis identifies CHOP as a specific regulator of hepatocyte ballooningY Zhang, I Chatzistamou, H Kiaris
Oncogene|May 17, 2016
A CCL8 gradient drives breast cancer cell disseminationE Farmaki, I Chatzistamou, V Kaza, et al.
BMC Genomics|April 22, 2021
Resilience, plasticity and robustness in gene expression during aging in the brain of outbred deer miceE Soltanmohammadi, Y Zhang, I Chatzistamou, et al.
British Journal of Cancer|September 6, 2000
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonistsI Chatzistamou, A V Schally, B Sun, et al.
Molecular and Cellular Biochemistry|September 15, 2004
Tumour-stroma interactions in carcinogenesis: basic aspects and perspectivesH Kiaris, I Chatzistamou, Ch Kalofoutis, et al.
Cancer Letters|August 4, 2001
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist CetrorelixI Chatzistamou, A V Schally, K Szepeshazi, et al.
Experimental Gerontology|December 8, 2020
Coordination in the unfolded protein response during aging in outbred deer miceE Soltanmohammadi, E Farmaki, Y Zhang, et al.
Journal of Cancer Research and Clinical Oncology|November 17, 2001
Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptideI Chatzistamou, A V Schally, J L Varga, et al.
European Journal of Gynaecological Oncology|October 21, 2004
Extraovarian mullerian-type cystic tumors of the female. A report of six cases and review of the literatureA Kondi-Pafiti, K Papadias, E Kairi-Vassilatou, et al.
Anti-Cancer Drugs|October 11, 2001
Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormoneI Chatzistamou, A V Schally, J L Varga, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cell Stress & Chaperones|June 25, 2020
Coordination of the unfolded protein response during hepatic steatosis identifies CHOP as a specific regulator of hepatocyte ballooningY Zhang, I Chatzistamou, H Kiaris
Oncogene|May 17, 2016
A CCL8 gradient drives breast cancer cell disseminationE Farmaki, I Chatzistamou, V Kaza, et al.
BMC Genomics|April 22, 2021
Resilience, plasticity and robustness in gene expression during aging in the brain of outbred deer miceE Soltanmohammadi, Y Zhang, I Chatzistamou, et al.
British Journal of Cancer|September 6, 2000
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonistsI Chatzistamou, A V Schally, B Sun, et al.
Molecular and Cellular Biochemistry|September 15, 2004
Tumour-stroma interactions in carcinogenesis: basic aspects and perspectivesH Kiaris, I Chatzistamou, Ch Kalofoutis, et al.
Cancer Letters|August 4, 2001
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist CetrorelixI Chatzistamou, A V Schally, K Szepeshazi, et al.
Experimental Gerontology|December 8, 2020
Coordination in the unfolded protein response during aging in outbred deer miceE Soltanmohammadi, E Farmaki, Y Zhang, et al.
Journal of Cancer Research and Clinical Oncology|November 17, 2001
Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptideI Chatzistamou, A V Schally, J L Varga, et al.
European Journal of Gynaecological Oncology|October 21, 2004
Extraovarian mullerian-type cystic tumors of the female. A report of six cases and review of the literatureA Kondi-Pafiti, K Papadias, E Kairi-Vassilatou, et al.
Anti-Cancer Drugs|October 11, 2001
Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormoneI Chatzistamou, A V Schally, J L Varga, et al.
Pageof 2